Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

NCT05868382 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
270
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ModernaTX, Inc.